argenx SE reported $35.57M in Loan Capital for its fiscal quarter ending in June of 2025.





Loan Capital Change Date
AstraZeneca USD 25.96B 177M Mar/2026
Genmab DKK 5.14B 5.01B Dec/2025
GlaxoSmithKline GBP 14.01B 696M Mar/2026
GRIFOLS EUR 9.08B 612M Mar/2026
Hikma Pharmaceutical USD 1.49B 692M Dec/2025
Lakefront Biotherapeutics EUR 4.85M 335K Mar/2026
Qiagen NV USD 1.65B 15.23M Dec/2025
UCB EUR 2.18B 634M Dec/2025